급성 일산화탄소 중독 환자에서 응급실 내원 초기 동맥혈 이산화탄소 분압의 임상적 의미

Purpose: The objective was to determine the association between PaCO 2 and adverse cardiovascular events (ACVEs) in carbon monoxide (CO)-poisoned patients. Methods: This retrospective study included 194 self-breathing patients after CO poisoning with an indication for hyperbaric oxygen therapy and a...

Full description

Saved in:
Bibliographic Details
Published in대한임상독성학회지 Vol. 17; no. 2; pp. 86 - 93
Main Authors 양근모, Keun Mo Yang, 전병조, Byeong Jo Chun, 문정미, Jeong Mi Moon, 조용수, Young Soo Cho
Format Journal Article
LanguageKorean
Published 대한임상독성학회 30.12.2019
Subjects
Online AccessGet full text
ISSN1738-1320
2508-6332
DOI10.22537/jksct.2019.17.2.86

Cover

More Information
Summary:Purpose: The objective was to determine the association between PaCO 2 and adverse cardiovascular events (ACVEs) in carbon monoxide (CO)-poisoned patients. Methods: This retrospective study included 194 self-breathing patients after CO poisoning with an indication for hyperbaric oxygen therapy and available arterial blood gas analysis at presentation and 6 hours later. The baseline characteristics and clinical course during hospitalization were collected and compared. The mean PaCO 2 during the first 6 hours after presentation was calculated. Results: The incidence rates of moderate (30 mmHg< PaCO 2 <35 mmHg) or severe (PaCO 2 ≤30 mmHg) hypocapnia at presentation after acute CO poisoning were 40.7% and 26.8%, respectively. The mean PaCO 2 during the first 6 hours was 33 (31-36.7) mmHg. The incidence of ACVEs during hospitalization was 50.5%. A significant linear trend in the incidence of ACVEs was observed across the total ranges of PaCO 2 variables. In multivariate regression analysis, mean PaCO 2 was independently associated with ACVEs (OR 0.798 (95% CI 0.641-0.997)). Conclusion: Mean PaCO 2 during the first 6 hours was associated with increased ACVEs. Given the high incidence of ACVEs and PaCO 2 derangement and the observed association between PaCO 2 and ACVEs, this study suggests that 1) PaCO 2 should be monitored at the acute stage to predict and/or prevent ACVEs; and 2) further study is needed to validate this result and investigate early manipulation of PaCO 2 as treatment.
Bibliography:Korean Society of Clinical Toxicology
KISTI1.1003/JNL.JAKO201912062688711
ISSN:1738-1320
2508-6332
DOI:10.22537/jksct.2019.17.2.86